Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Importance: The number of cancer survivors who develop new cancers is projected to increase, but comprehensive data on the risk of subsequent primary cancers (SPCs) among survivors of adult-onset cancers are limited. Objective: To quantify the overall and cancer type-specific risks of SPCs among adult-onset cancer survivors by first primary cancer (FPC) types and sex. Design, Setting, and Participants: A retrospective cohort study from 12 Surveillance, Epidemiology, and End Results registries in the United States, that included 1 537 101 persons aged 20 to 84 years diagnosed with FPCs from 1992-2011 (followed up until December 31, 2017) and who survived at least 5 years. Exposures: First primary cancer. Main Outcomes and Measures: Incidence and mortality of SPCs per 10 000 person-years; standardized incidence ratio (SIR) and standardized mortality ratio (SMR) compared with those expected in the general population. Results: Among 1 537 101 survivors (mean age, 60.4 years; 48.8% women), 156 442 SPC cases and 88 818 SPC deaths occurred during 11 197 890 person-years of follow-up (mean, 7.3 years). Among men, the overall risk of developing any SPCs was statistically significantly higher for 18 of the 30 FPC types, and risk of dying from any SPCs was statistically significantly higher for 27 of 30 FPC types as compared with risks in the general population. Among women, the overall risk of developing any SPCs was statistically significantly higher for 21 of the 31 FPC types, and risk of dying from any SPCs was statistically significantly higher for 28 of 31 FPC types as compared with risks in the general population. The highest overall SIR and SMR were estimated among survivors of laryngeal cancer (SIR, 1.75 [95% CI, 1.68-1.83]; incidence, 373 per 10 000 person-years) and gallbladder cancer (SMR, 3.82 [95% CI, 3.31-4.39]; mortality, 341 per 10 000 person-years) among men, and among survivors of laryngeal cancer (SIR, 2.48 [95% CI, 2.27-2.72]; incidence, 336 per 10 000 person-years; SMR, 4.56 [95% CI, 4.11-5.06]; mortality, 268 per 10 000 person-years) among women. Substantial variation existed in the associations of specific types of FPCs with specific types of SPC risk; however, only a few smoking- or obesity-associated SPCs, such as lung, urinary bladder, oral cavity/pharynx, colorectal, pancreatic, uterine corpus, and liver cancers constituted considerable proportions of the total incidence and mortality, with lung cancer alone accounting for 31% to 33% of mortality from all SPCs. Conclusions and Relevance: Among survivors of adult-onset cancers in the United States, several types of primary cancer were significantly associated with greater risk of developing and dying from an SPC, compared with the general population. Cancers associated with smoking or obesity comprised substantial proportions of overall SPC incidence and mortality among all survivors and highlight the importance of ongoing surveillance and efforts to prevent new cancers among survivors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer treatment and survivorship statistics, 2019
Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21565 · Cited by 4,226
Self-citationBody Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
The United Nations Scientific Committee on the Effects of Atomic Radiation
(1965) · Nature · doi:10.1038/206014c0 · Cited by 1,636
Bluethmann, S. M., Mariotto, A. B., & Rowland, J. H. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0133 · Cited by 1,146
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3809 · Cited by 1,071
Self-citationRunowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens‐Alvarado, R. L., Cannady, R. S., Pratt‐Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21319 · Cited by 728
Self-citationNew malignancies among cancer survivors: SEER Cancer Registries, 1973-2000.
Curtis, R. E., Freedman, D. M., Ron, E., Ries, L. A. G., Hacker, D. G., Edwards, B. K., Tucker, M., & Fraumeni, J. F. (2006) · Cited by 527
Economic Burden of Cancer in the United States: Estimates, Projections, and Future Research
Yabroff, K. R., Lund, J., Kepka, D., & Mariotto, A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0650 · Cited by 503
Self-citationAmerican Cancer Society Colorectal Cancer Survivorship Care Guidelines
El‐Shami, K., Oeffinger, K. C., Erb, N. L., Willis, A., Bretsch, J. K., Pratt‐Chapman, M. L., Cannady, R. S., Wong, S. L., Rose, J., Barbour, A. L., et al. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21286 · Cited by 475
Radiation induced secondary malignancies: a review article
Dracham, C. B., Shankar, A., & Madan, R. (2018) · Radiation Oncology Journal · doi:10.3857/roj.2018.00290 · Cited by 349
Berrington de Gonzalez, A., Gilbert, E., Curtis, R., Inskip, P., Kleinerman, R., Morton, L., Rajaraman, P., & Little, M. P. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.09.001 · Cited by 279
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors
Travis, L. B., Wahnefried, W. D., Allan, J. M., Wood, M. E., & Ng, A. K. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.41 · Cited by 264
Morton, L. M., Dores, G. M., Schonfeld, S. J., Linet, M. S., Sigel, B. S., Lam, C. J. K., Tucker, M. A., & Curtis, R. E. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5625 · Cited by 199
Increased risk of second malignant neoplasms in adolescents and young adults with cancer
Lee, J. S., DuBois, S. G., Coccia, P. F., Bleyer, A., Olin, R. L., & Goldsby, R. E. (2016) · Cancer · doi:10.1002/cncr.29685 · Cited by 182
Bright, C. J., Reulen, R. C., Winter, D. L., Stark, D., McCabe, M. G., Edgar, A. B., Frobisher, C., & Hawkins, M. M. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30903-3 · Cited by 167
Murphy, C. C., Gerber, D. E., & Pruitt, S. L. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3605 · Cited by 163
Trends in Radiation Therapy among Cancer Survivors in the United States, 2000–2030
Bryant, A. K., Banegas, M. P., Martínez, M. E., Mell, L. K., & Murphy, J. D. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-1023 · Cited by 158
Druesne‐Pecollo, N., Touvier, M., Barrandon, É., Chan, D. S. M., Norat, T., Zelek, L. H., Herçberg, S., & Latino‐Martel, P. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2187-1 · Cited by 137
Smoking Behaviors in Survivors of Smoking-Related and Non–Smoking-Related Cancers
Gritz, E. R., Talluri, R., Domgue, J. F., Tamí‐Maury, I., & Shete, S. S. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.9072 · Cited by 115
Harlan, L. C., & Hankey, B. F. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.94.023 · Cited by 111
Sarcoma risk after radiation exposure
de González, A. B., Kutsenko, A., & Rajaraman, P. (2012) · Clinical Sarcoma Research · doi:10.1186/2045-3329-2-18 · Cited by 100
Yasui, Y. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg278 · Cited by 96
Gibson, T. M., Park, Y., Robien, K., Shiels, M. S., Black, A., Sampson, J. N., Purdue, M. P., Freeman, L. E. B., Andreotti, G., Weinstein, S. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.8444 · Cited by 88
Gilbert, D. C., Wakeham, K., Langley, R. E., & Vale, C. L. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0273-9 · Cited by 84
Hessol, N. A., Whittemore, H., Vittinghoff, E., Hsu, L. C., Ma, D., Scheer, S., & Schwarcz, S. K. (2018) · The Lancet HIV · doi:10.1016/s2352-3018(18)30179-6 · Cited by 81
Smoking cessation attitudes and practices among cancer survivors – United States, 2015
Gallaway, M. S., Glover‐Kudon, R., Momin, B. R., Puckett, M., Lunsford, N. B., Ragan, K. R., Rohan, E. A., & Babb, S. D. (2019) · Journal of Cancer Survivorship · doi:10.1007/s11764-018-0728-2 · Cited by 55
Boakye, E. A., Buchanan, P. M., Hinyard, L., Osazuwa‐Peters, N., Simpson, M. C., Schootman, M., & Piccirillo, J. F. (2019) · International Journal of Cancer · doi:10.1002/ijc.32101 · Cited by 54
Neumann, F., Jegu, J., Mougin, C., Prétet, J., Guizard, A., Lapôtre‐Ledoux, B., Bara, S., Bouvier, V., Colonna, M., Troussard, X., et al. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.06.041 · Cited by 45
Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy
Mukhtar, F., Ilozumba, M. N., Utuama, O. A., & Cimenler, O. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.2395 · Cited by 22
Age- and treatment-related associations with health behavior change among breast cancer survivors
Anderson, C., Sandler, D. P., Weinberg, C. R., Houck, K. L., Chunduri, M., Hodgson, M. E., Sabatino, S. A., White, M. C., Rodriguez, J. L., & Nichols, H. B. (2017) · The Breast · doi:10.1016/j.breast.2017.02.013 · Cited by 21
Has the Quality of Patient–Provider Communication About Survivorship Care Improved?
Rai, A., Chawla, N., Han, X., Rim, S. H., Smith, T. G., de Moor, J. S., & Yabroff, K. R. (2019) · Journal of Oncology Practice · doi:10.1200/jop.19.00157 · Cited by 14
Self-citation
Cited by
Management of common clinical problems experienced by survivors of cancer
Emery, J., Butow, P., Lai-Kwon, J., Nekhlyudov, L., Rynderman, M., & Jefford, M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00242-2 · Cited by 326
Lustberg, M. B., Kuderer, N. M., Desai, A., Bergerot, C., & Lyman, G. H. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00776-9 · Cited by 306
Systematic Review and Meta-Analysis of the Impact of Bariatric Surgery on Future Cancer Risk
Wilson, R. B., Lathigara, D., & Kaushal, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076192 · Cited by 144
Metadata
- Authors
- Sung, H., Hyun, N., Leach, C. R., Yabroff, K. R., & Jemal, A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2020-12-22
- Volume
- 324
- Issue
- 24
- Pages
- 2521
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3113985876
- Cited by
- 218
- References
- 32
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.